MEDS DataMEDS AI Inc.

$MEDS NASDAQ blocking shorts attempting to manipulate the ask with SSR in place canceling short orders🔥⬆️✅👌

$MEDS $XRPN can’t wait for tommorow 🙏😇 good luck to all make sure yall take some profits and keep it running. Gotta make sure you feed your families!!! Happy Thursday

$MEDS I was going to chase this AH and something pulled me back, glad I didn’t decide to chase it although tomorrow it could open higher, I will take a closer look at this tomorrow, to everyone invested good luck

$MEDS be careful here: deadline approaching DataMeds AI, Inc. (NASDAQ: MEDS) faces a crucial compliance deadline on October 12, 2026. The company was granted an extension by Nasdaq to demonstrate compliance with the minimum stockholders' equity requirement of $2.5 million required for continued listing on the Nasdaq Capital Market.

$MEDS Datavault could be a major catalyst...exclusivity period ended Sept. 30 1. Closing still pending: MEDS lists the Datavault Transaction closing as a remaining H2 2026 milestone. 2. Much more than a partnership: The deal combines Datavault healthcare technology/licensing, QOLPOM IP and control of Tollo Health/Health Lives Here. 3. DVLT becomes a major shareholder: Proposed structure gives Datavault 19.9% of MEDS on a fully diluted basis. EOS and Scilex are also contemplated at 19.9% each. 4. Key condition already met: MEDS raised $6.5M, explicitly satisfying the deal’s capital-raising closing condition. 5. Timing is interesting: The LOI exclusivity period ended Sept. 30. No termination has been announced. 6. Dilution ≠ immediate float: The deal contemplates transfer restrictions and a 6-month lock-up for certain holders. A closing announcement could therefore be a major MEDS catalyst.

$MEDS 1) Corexa growth: September preliminary revenue exceeded $1M, up 66%+ from July’s $600K+, implying a $12M+ annualized run rate if sustained. 2) Extreme borrow pressure: Last observed data showed 0 shares available to borrow and CTB around 539%. 3) Heavy short positioning: Reported short interest was ~430K shares / 33.85% of float, creating potential squeeze fuel if momentum returns. 4) Reg SHO Threshold: MEDS has been on the Threshold Securities List, indicating persistent settlement failures. Combined with scarce borrow, this matters. 5) Technical setup: Day 2 defended the $3.59–$3.60 support zone after Thursday’s +28% move. Monday is Day 3. A reclaim of $4+ could bring momentum back quickly.

$MEDS slowly heating up while shorts try cover buyers pick it up on the scanners and will pile in to squeeze them past 12

$MEDS from the high level of short interest not all shorts can cover at these prices, turn your sell orders off, this should take off past 12

$MEDS watched lowball orders here go unfulfilled yesterday when the entire market was rolling over. So yes I’ll be buying the dip today.

$MEDS $3.35> center of FVG on 15 min chart and also the 9ema> may get back to last weeks high line $4.6

$MEDS My prediction is that this dumps at open followed by an all day move up into green where it finally closes above $4

$MEDS Speculative retail and long-term community discussions have floated wide informal targets ranging between $6.89 and $25.00, t

Up 27% today. $MEDS just reported its Corexa Pharmacy topped $1M in monthly revenue in September, up 66% since July, riding the GLP-1 dispensing wave. Small cap, big momentum.

$MEDS Profits were took. Weak hands were shook out. They still will try and shake the tree. Rsi was hot it cooled off. Now we see what happens. Scared money doesn’t make money imo. NFA

$MEDS 4.00 support play!🔥 DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue

$MEDS Update 60' chart- Prices above my personal adaptative indicator violet, it works as a dynamic support.Breakout of downtrend line with GAP 🤞😎 It's important to break 4.55

$MEDS if it can’t get above $3.20 don’t bother with it the short just sends it sideways covering

$MEDS such an impressive play this morning from the shorts. Returned their shares, let people think buyers were driving the increase, then squashed them right back down to where it was before.

$MEDS short interest still super high at 37% with a 600% borrow rate, not sure we might a short squeeze soon with such low float… not sure whether to be bullish or bearish at this point but my avg is $3.34 @ 10k shares

$MEDS This short trying to lower it is going too learn the hard way that they’re the only one selling it below $4